Glycoprotein Iib/Iiia Antagonists: Do They Have a Role in the Management of Unstable Angina?
Why the study?
Do glycoprotein IIb/IIIa antagonists improve outcomes in patients with non-ST segment elevation acute coronary syndromes?
Population
Patients with non-ST segment elevation acute coronary syndromes (unstable angina)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Uncertain role for glycoprotein IIb/IIIa antagonists in NSTE-ACS; leaves open need for updated randomized evidence synthesis.
Structured PICO
Do glycoprotein IIb/IIIa antagonists improve outcomes in patients with non-ST segment elevation acute coronary syndromes?
P
Population
Patients with non-ST segment elevation acute coronary syndromes (unstable angina)
I
Intervention
Glycoprotein IIb/IIIa antagonists (intravenous and oral)
This article reviews the evidence for using glycoprotein IIb/IIIa antagonists in patients with non-ST segment elevation acute coronary syndromes.
Cite This Study
Redwood et al. (1999) studied this question.